patient care perspectives

Risk-Adapted Post-Transplant Maintenance Therapy in Multiple Myeloma
Oncology

Risk-Adapted Post-Transplant Maintenance Therapy in Multiple Myeloma

patient care perspectives
By Kenneth C. Anderson, MD
Optimal Treatment Approaches for Indolent Mantle Cell Lymphoma
Oncology

Optimal Treatment Approaches for Indolent Mantle Cell Lymphoma

patient care perspectives
By Brad Kahl, MD
Prognostic Marker Testing in Treatment-Naive Patients With Chronic Lymphocytic Leukemia
Oncology

Prognostic Marker Testing in Treatment-Naive Patients With Chronic Lymphocytic Leukemia

patient care perspectives
By William G. Wierda, MD, PhD
Patient and Physician Decision Making on the Use of Novel Agents in Chronic Lymphocytic Leukemia
Oncology

Patient and Physician Decision Making on the Use of Novel Agents in Chronic Lymphocytic Leukemia

patient care perspectives
Bruton Tyrosine Kinase Inhibitor Eligibility in Relapsed/Refractory Mantle Cell Lymphoma
Oncology

Bruton Tyrosine Kinase Inhibitor Eligibility in Relapsed/Refractory Mantle Cell Lymphoma

patient care perspectives
By John M. Pagel, MD, PhD
Load More